Skip to main content
S&P 5007,622.14-0.20%DOW51,561.39-0.42%NASDAQ26,385.09-0.13%BTC$80,825.00+5.45%ETH$2,588.67+4.89%GOLD$4,394.90-0.11%OIL$96.84-0.40%
Smart Investors Daily
NB

NASDAQ · NBSE

NeuBase Therapeutics, Inc.

Healthcare · Biotechnology

$0.38

Down-$0.01 (-1.56%)

Updated Sep 18, 2026, 4:13 PM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.42M
P/E ratio
-0.02
Dividend yield
0.00%
52-week range
— – —
Volume
89.7K
Avg. volume
126.56K

Price performance

NBSE price history

1M range · 0 trading sessions · Daily adjusted prices

NBSE does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest NBSE news

The latest Smart Investors Daily articles mentioning NBSE.

Stock researchCompany · Overview

NBSE research

Overview

Company profile and research snapshot.

Company profile

NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its lead programs include NT0100, a PATrOL enabled anti-gene for Huntington's disease; NT0200, a PATrOL enabled anti-gene for myotonic dystrophy type 1; NT0300, a PATrOL-enabled therapeutic treatment to target the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
NBSE recent ratings
DateFirmRatingTarget
Oct 21, 2022OppenheimerPerform—
Oct 18, 2022RBC CapitalSector Perform—
Oct 17, 2022Chardan CapitalNeutral—
Aug 12, 2022Chardan CapitalBuy—
May 31, 2022HC Wainwright & Co.Buy—
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Mar 26, 2024

Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Tuesday. The Dow traded up 0.08% to 39,346.40 while the NASDAQ rose 0.39% to 16,448.92. The S&P 500 also rose, gaining, 0.23% to 5,230.19. Check This Out: Top 3 Energy Stocks That May Keep You Up At Night In Q1   Leading and Lagging Sectors   Consumer discretionary shares jumped by 0.7% on Monday. In trading on Monday, energy shares fell by 0.2%.   Top Headline   U.S. durable goods orders increased by 1.4% month-over-month in February versus a revised 6.9% decline in January.   Equities Trading UP   Stoke Therapeutics, Inc. (NASDAQ: STOK) shares shot up 74% to $11.31 after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome. Shares of C3is Inc. (NASDAQ: CISS) got a boost, surging 67% to $0.0587 after the company reported a year-over-year increase in fourth-quarter financial results. OpGen, Inc. (NASDAQ: OPGN) shares were ...

Benzinga · Feb 26, 2024

Why Intuitive Machines Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket

Shares of Intuitive Machines, Inc. (NASDAQ: LUNR) fell sharply in today’s pre-market trading. Intuitive Machines revealed Friday that its lunar lander, Odysseus, encountered a mishap during a touchdown near the moon’s south pole. Intuitive Machines shares dipped 30.1% to $6.71 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) gained 66% to $1.33 in pre-market trading after surging over 30% on Friday. Semilux International Ltd. (NASDAQ: SELX) shares rose 43.9% to $1.64 in pre-market trading after dipping 21% on Friday. Rubicon Technologies, Inc. (NYSE: RBT) shares gained 14.8% to $0.9699 in pre-market trading. NeuBase Therapeutics, Inc. (NASDAQ: NBSE) shares surged 14.5% to $0.86 in pre-market trading. Neubase Therapeutics, on Feb. 22, said board determined for company to dissolve, liquidate and distribute to stockholders its available assets. 23andMe Holding Co. (NASDAQ: ME) shares jumped 13.2% to $0.6398 in pre-market trading after ...

Benzinga · Oct 26, 2023

Why Endeavor Group Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket

Gainers Appreciate Holdings, Inc. (NASDAQ: SFR) shares surged 103.8% to $0.2460 in pre-market trading after falling around 19% on Wednesday. Appreciate Holdings received a notice from Nasdaq regarding delisting. NextPlay Technologies, Inc. (NASDAQ: NXTP) shares gained 56.5% to $0.7174 in pre-market trading after falling 21% on Wednesday. NextPlay Technologies received a notice from Nasdaq regarding a delayed second-quarter report. IM Cannabis Corp. (NASDAQ: IMCC) shares climbed 48.1% to $0.31 in pre-market trading. Jaguar Global Growth Corporation I (NASDAQ: JGGC) shares rose 23.4% to $8.12 in pre-market trading after gaining over 18% on Wednesday. Endeavor Group Holdings, Inc. (NYSE: EDR) rose 22.7% to $21.74 in pre-market trading after the company announced a review of strategic alternatives. Nxu, Inc. (NASDAQ: NXU) shares rose 15.9% to $0.0415 in pre-market trading. Nxu recently reported the closing of a $3.0 million public offering of common stock. Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 15.5% to $0.8665 in pre-market trading after falling around 14% on Wednesday. Mangoceuticals recently announced the official ...

Benzinga · Sep 14, 2023

Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for capeserod from Sanofi. PFSweb, Inc. (NASDAQ: PFSW) gained 48.3% to $7.43 after GXO Logistics announced it will acquire the company. TradeUP Acquisition Corp. (NASDAQ: UPTD) shares climbed 45.8% to $11.08. Taseko Mines Limited (NYSE: TGB) gained 22.3% to $1.59. Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares gained 22% to $0.2730 after jumping 81% on Wednesday. Avalo Therapeutics recently agreed to divest AVTX-800 series. NeuBase Therapeutics, Inc. (NASDAQ: NBSE) gained 20.3% to $1.48. Symetryx said on Sept. 13, 2023, sent an email to Neubase proposing a specific company as a potential merger candidate and will facilitate an introduction to this potential merger candidate if there is interest. MYT Netherlands Parent B.V. (NASDAQ: MYTE) jumped 15.4% to $4.3300 after the company reported fourth-quarter financial results. Soluna Holdings, Inc. (NASDAQ: SLNH) gained 13.4% to $0.2064 after reporting a narrower quarterly loss. Nikola Corporation (NASDAQ: NKLA) jumped 13.4% to $0.9869. Nikola CEO Steve Girsky on Wednesday termed the several cases of fire reported with its battery electric trucks a ‘setback’ and detailed the measures being undertaken to fix the issue. Trinseo PLC (NYSE: TSE) rose 11.9% to $8.84. Alaunos Therapeutics, Inc. (NASDAQ: TCRT) surged 11.4% to $0.1360. Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) jumped 11.1% to $5.72. Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) rose 10.4% to $0.4525. Eiger BioPharmaceuticals shares ...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By